rac-N-(1-(3-amino-5-chlorobenzo[d]isoxazol-7-yl)pyrrolidin-3-yl)-2-chloro-4-(4H-1,2,4-triazol-4-yl)benzamide

ID: ALA4090664

PubChem CID: 118456935

Max Phase: Preclinical

Molecular Formula: C20H17Cl2N7O2

Molecular Weight: 458.31

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Nc1noc2c(N3CCC(NC(=O)c4ccc(-n5cnnc5)cc4Cl)C3)cc(Cl)cc12

Standard InChI:  InChI=1S/C20H17Cl2N7O2/c21-11-5-15-18(31-27-19(15)23)17(6-11)28-4-3-12(8-28)26-20(30)14-2-1-13(7-16(14)22)29-9-24-25-10-29/h1-2,5-7,9-10,12H,3-4,8H2,(H2,23,27)(H,26,30)

Standard InChI Key:  ZVKYDZGKVABJSX-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
    8.7524  -16.1333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7513  -16.9528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4593  -17.3618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1690  -16.9524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1662  -16.1297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4575  -15.7244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0446  -15.7249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0444  -14.9077    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3370  -16.1336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6292  -15.7252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5432  -14.9136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7438  -14.7439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3354  -15.4517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8824  -16.0588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5247  -15.5391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0446  -14.8764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2326  -14.9617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8997  -15.7090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1951  -16.2832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3814  -16.3757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2179  -17.1783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9306  -17.5818    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5345  -17.0286    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4742  -17.5169    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4551  -14.9072    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.8773  -17.3598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9646  -18.1700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7642  -18.3387    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1717  -17.6303    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.6239  -17.0239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7524  -14.3005    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 20  1  0
 19 15  1  0
 13 15  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 19  1  0
 21 24  1  0
  6 25  1  0
  4 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 26  1  0
 17 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4090664

   N-[1-(3-amino-5-chloro-1,2-benzoxazol-7-yl)pyrrolidin-3-yl]-2-chloro-4-(1,2,4-triazol-4-yl)benzamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 458.31

Molecular Weight (Monoisotopic): 457.0821

AlogP: 3.31

#Rotatable Bonds: 4

Polar Surface Area: 115.10

Molecular Species: NEUTRAL

HBA: 8

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 2.58

CX LogP: 2.07

CX LogD: 2.07

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.48

Np Likeness Score: -1.95

References

1. Sakurada I, Endo T, Hikita K, Hirabayashi T, Hosaka Y, Kato Y, Maeda Y, Matsumoto S, Mizuno T, Nagasue H, Nishimura T, Shimada S, Shinozaki M, Taguchi K, Takeuchi K, Yokoyama T, Hruza A, Reichert P, Zhang T, Wood HB, Nakao K, Furusako S..  (2017)  Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors.,  27  (11): [PMID:28408226] [10.1016/j.bmcl.2017.03.002]

Source

Source(1):

• Scientific Literature